Citation Impact
Citing Papers
Systematic Review: Evaluating the Effect of Lipid-Lowering Therapy on Lipoprotein and Lipid Values
2013
Microbiota in health and diseases
2022 Standout
Metabolic dysregulation in vitamin E and carnitine shuttle energy mechanisms associate with human frailty
2019
Cell type-selective secretome profiling in vivo
2020 StandoutNobel
Fructose and sugar: A major mediator of non-alcoholic fatty liver disease
2018
Non-alcoholic fatty liver disease – A global public health perspective
2018 Standout
Hallmarks of aging: An expanding universe
2023 Standout
Gut microbiome and health: mechanistic insights
2022 Standout
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
2016 Standout
“Sweet death”: Fructose as a metabolic toxin that targets the gut-liver axis
2021
Divergent effects of glucose and fructose on hepatic lipogenesis and insulin signaling
2017
Rates of and Factors Associated With Placebo Response in Trials of Pharmacotherapies for Nonalcoholic Steatohepatitis: Systematic Review and Meta-analysis
2018
Antioxidant therapy for treatment of inflammatory bowel disease: Does it work?
2015 Standout
Gut–liver axis, nutrition, and non-alcoholic fatty liver disease
2015
Role of Dietary Fructose and Hepatic De Novo Lipogenesis in Fatty Liver Disease
2016
Dietary carbohydrates and fats in nonalcoholic fatty liver disease
2021
Inflammation in obesity, diabetes, and related disorders
2022 Standout
The gut–liver axis and the intersection with the microbiome
2018
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Computational Metabolomics: A Framework for the Million Metabolome
2016
Non-Alcoholic Fatty Liver Disease in Children: Focus on Nutritional Interventions
2014
MetaboAnalystR: an R package for flexible and reproducible analysis of metabolomics data
2018 Standout
Per- and Polyfluoroalkyl Substance Toxicity and Human Health Review: Current State of Knowledge and Strategies for Informing Future Research
2020 Standout
Quantitative Serum Nuclear Magnetic Resonance Metabolomics in Cardiovascular Epidemiology and Genetics
2015 Standout
The Role of Dietary Sugars and De novo Lipogenesis in Non-Alcoholic Fatty Liver Disease
2014
Bioinformatics Tools for the Interpretation of Metabolomics Data
2017
Per- and polyfluoroalkyl substances in the environment
2022 StandoutScience
Serum metabolite profiling yields insights into health promoting effect of A. muciniphila in human volunteers with a metabolic syndrome
2021
MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights
2021 Standout
Works of Ran Jin being referenced
Perfluoroalkyl substances, metabolomic profiling, and alterations in glucose homeostasis among overweight and obese Hispanic children: A proof-of-concept analysis
2019
Perfluoroalkyl substances and severity of nonalcoholic fatty liver in Children: An untargeted metabolomics approach
2019
Amino Acid Metabolism is Altered in Adolescents with Nonalcoholic Fatty Liver Disease—An Untargeted, High Resolution Metabolomics Study
2016
Children with NAFLD Are More Sensitive to the Adverse Metabolic Effects of Fructose Beverages than Children without NAFLD
2012
Changes in Lipoprotein Particle Number with Ezetimibe/Simvastatin Co-administered with Extended-Release Niacin in Patients with Type II Hyperlipidemia†
2012
Fructose Induced Endotoxemia in Pediatric Nonalcoholic Fatty Liver Disease
2014
Changes in Lipoprotein Particle Number With Ezetimibe/Simvastatin Coadministered With Extended‐Release Niacin in Hyperlipidemic Patients
2013
500 Losartan Improves Hepatic Inflammation in Children With Non-Alcoholic Fatty Liver Disease
2016
CHANGES IN LIPOPROTEIN PARTICLE NUMBER WITH EZETIMIBE/SIMVASTATIN COADMINISTERED WITH EXTENDED-RELEASE NIACIN IN PATIENTS WITH TYPE II HYPERLIPIDEMIA
2012
Dietary Fructose Reduction Improves Markers of Cardiovascular Disease Risk in Hispanic-American Adolescents with NAFLD
2014